Indirect comparison for Anti-TNF drugs in moderate to severe ulcerative colitis
Objective: To compare the relative efficacy of infliximab, adalimumab and golimumab through adjusted indirect treatment comparisons (ITCs). Methods: An exhaustive search was performed until October 2013. Databases consulted were MEDLINE, EMBASE, the Cochrane Library, the Centre for Reviews and Disse...
Saved in:
Main Authors: | M. Galván-Banqueri (Author), M. D. Vega-Coca (Author), M. A. Castillo-Muñoz (Author), C. Beltrán Calvo (Author), T. Molina López (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-Effectiveness Analysis of Vedolizumab Compared With Infliximab in Anti-TNF-α-Naïve Patients With Moderate-to-Severe Ulcerative Colitis in China
by: Ting Zhou, et al.
Published: (2021) -
Biologics for the treatment of moderate- to-severe ulcerative colitis in pediatric patients
by: Albenberg LG, et al.
Published: (2012) -
Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab
by: Freeman HJ
Published: (2013) -
Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study
by: Kenji Suzuki, et al.
Published: (2024) -
Exposure‐response relationships of etrolizumab in patients with moderately‐to‐severely active ulcerative colitis
by: Nastya Kassir, et al.
Published: (2022)